TriSalus Life Sciences, Inc. (TLSIW) Net income 2021–2025
TriSalus Life Sciences, Inc. (TLSIW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$39.2MFY2025 · since FY2021: $4.8M → -$39.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.2M | -30.6% |
| FY2024 | -$30.0M | +49.4% |
| FY2023 | -$59.4M | -25.8% |
| FY2022 | -$47.2M | -1089.8% |
| FY2021 | $4.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net marginTLSIW Gross profitTLSIW Gross marginTLSIW Operating incomeTLSIW Operating marginTLSIW Operating cash flowTLSIW Free cash flowTLSIW Capital expendituresTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Total liabilitiesTLSIW Shareholders’ equityTLSIW overview →